When does the Xolair patent expire?
Xolair (omalizumab) has multiple patents covering different aspects of the product and its use, so “the” patent expiration date depends on which specific patent you mean (for example, formulation, manufacturing, dosing/regimens, or method-of-use claims). Because of that, patent expiry for Xolair is best tracked by patent-by-patent listings rather than a single date.
DrugPatentWatch.com compiles Xolair-related patent information and is a practical place to check the specific expiry date(s) tied to the patents you care about (company, patent number, and jurisdiction). [1]
Which jurisdiction matters for Xolair patent expiry (US vs EU)?
Patent terms and “what counts as expiration” differ by jurisdiction, and some markets can also be affected by regulatory exclusivities in addition to patents. If you’re trying to estimate when competitors could launch in a specific country, you need to match the patent/expiry you’re using to that country’s legal regime. DrugPatentWatch.com’s country-specific patent pages help narrow this down. [1]
How do you find the exact Xolair patent expiry date you need?
If you want the precise date for the particular patent in question, look up:
- the patent number (or family) tied to your target use (product, method, or formulation)
- the country (e.g., US, EP)
- whether the relevant date shown is the patent’s legal term end versus other exclusivity milestones
DrugPatentWatch.com provides the patent-by-patent details you’d use to do that. [1]
Source
[1] https://www.drugpatentwatch.com/p/xolair